Autopsy report · NCT02027532

Prevention of Infection in Closed Fractures: Cefazolin Versus Vancomycin

“Could not complete study due to administrative challenges”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 years 3 months after it had already started.
• Ran for about 8 years 2 months before it stopped.
• 430 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of Tennessee

Sponsor type

University, hospital or other

Conditions

Infection; Closed Fractures

Interventions

Cefazolin; Vancomycin

Participants

430

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.